letter · 2015
Hypoalbuminemia and hypergammaglobulinemia are associated with an increased infection risk in patients with myeloid malignancies treated with azacitidine. A 3-year monocentric retrospective study
International audience
5 citationsDOI: https://doi.org/10.3109/10428194.2015.1101096